178 participants
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL921 in Healthy Participants and Participants With Alzheimer's Disease
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-11
- Start Date:
- 2026-08-31
- Completion:
- 2030-04-30
Conditions
- Alzheimer's Disease
- Healthy Participants
Interventions
- DRUG
No Results Yet